PPARγ-targeting Potential for Radioprotection

E-ISSN： 1873-5592|19|15|1818-1830

ISSN： 1389-4501

Source： Current Drug Targets, Vol.19, Iss.15, 2018-12, pp. : 1818-1830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR-γ inhibitors as novel tubulin-targeting agents

By Schaefer Katherine L

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 923-926

Informa Healthcare

Access to resources Recommend Favorite

New Pharmacological Perspectives and Therapeutic Potential of PPAR-&ggr; Agonists

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3505-3524

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Novel Pentacyclic Triterpene Derivatives as Potential PPAR&ggr; Agonists

Medicinal Chemistry, Vol. 9, Iss. 1, 2013-02 ,pp. : 118-125

Bentham Science Publishers

Access to resources Recommend Favorite

New Light on An Old Friend: Targeting PUMA in Radioprotection and Therapy of Cardiovascular and Neurodegenerative Diseases

Current Drug Targets, Vol. 19, Iss. 16, 2018-12 ,pp. : 1943-1957

Bentham Science Publishers

Access to resources Recommend Favorite

The Influence of Tetracycline Inducible Targeting Rat PPAR? Gene Silencing on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells

Current Pharmaceutical Design, Vol. 22, Iss. 41, 2016-12 ,pp. : 6330-6338

Bentham Science Publishers

Access to resources Recommend Favorite